Harris, David T
Maggert, Keith A
AffiliationUniv Arizona, Coll Med, Dept Appl Biosci
Univ Arizona, Coll Med, Dept Pathol
Univ Arizona, Coll Med, Dept Med
Univ Arizona, Coll Med, Ctr Canc
Univ Arizona, Coll Med, Dept Immunobiol
Univ Arizona, Coll Med, Arizona Hlth Sci Ctr Biorepository
Univ Arizona, Coll Med, Dept Cellular & Mol Med
KeywordsRibosomal DNA (rDNA)
copy number polymorphism
invasive breast carcinoma
MetadataShow full item record
PublisherTAYLOR & FRANCIS INC
CitationVirginia Valori, Katalin Tus, Christina Laukaitis, David T. Harris, Lauren LeBeau & Keith A. Maggert (2019) Human rDNA copy number is unstable in metastatic breast cancers, Epigenetics, DOI: 10.1080/15592294.2019.1649930
Rights© 2019 Informa UK Limited, trading as Taylor & Francis Group.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractChromatin-mediated silencing, including the formation of heterochromatin, silent chromosome territories, and repressed gene promoters, acts to stabilize patterns of gene regulation and the physical structure of the genome. Reduction of chromatin-mediated silencing can result in genome rearrangements, particularly at intrinsically unstable regions of the genome such as transposons, satellite repeats, and repetitive gene clusters including the rRNA gene clusters (rDNA). It is thus expected that mutational or environmental conditions that compromise heterochromatin function might cause genome instability, and diseases associated with decreased epigenetic stability might exhibit genome changes as part of their aetiology. We find the support of this hypothesis in invasive ductal breast carcinoma, in which reduced epigenetic silencing has been previously described, by using a facile method to quantify rDNA copy number in biopsied breast tumours and pair-matched healthy tissue. We found that rDNA and satellite DNA sequences had significant copy number variation - both losses and gains of copies - compared to healthy tissue, arguing that these genome rearrangements are common in developing breast cancer. Thus, any proposed aetiology onset or progression of breast cancer should consider alterations to the epigenome, but must also accommodate concomitant changes to genome sequence at heterochromatic loci.
Note12 month embargo; published online: 12 August 2019
VersionFinal accepted manuscript
- Evolution of ribosomal DNA-derived satellite repeat in tomato genome.
- Authors: Jo SH, Koo DH, Kim JF, Hur CG, Lee S, Yang TJ, Kwon SY, Choi D
- Issue date: 2009 Apr 8
- Ribosomal DNA instability and genome adaptability.
- Authors: Salim D, Gerton JL
- Issue date: 2019 Mar
- Gene dosage compensation of rRNA transcript levels in Arabidopsis thaliana lines with reduced ribosomal gene copy number.
- Authors: Lopez FB, Fort A, Tadini L, Probst AV, McHale M, Friel J, Ryder P, Pontvianne FDR, Pesaresi P, Sulpice R, McKeown P, Brychkova G, Spillane C
- Issue date: 2021 May 31
- Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.
- Authors: Bae JS, Choi JS, Baik SH, Park WC, Song BJ, Kim JS, Lim Y, Jung SS
- Issue date: 2010 Apr 21
- Ribosomal DNA copy number loss and sequence variation in cancer.
- Authors: Xu B, Li H, Perry JM, Singh VP, Unruh J, Yu Z, Zakari M, McDowell W, Li L, Gerton JL
- Issue date: 2017 Jun